1 results match your criteria: "Critical Care Center Memorial Sloan Kettering Cancer Center[Affiliation]"
Utility of procalcitonin as a predictor of bloodstream infections and supportive modality requirements in critically ill cancer patients.
Clin Chim Acta
November 2020
Critical Care Center Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Background: We evaluated the diagnostic utility of procalcitonin (PCT) in predicting bacterial bloodstream infections (BSI) in critically ill cancer patients with and without neutropenia. We also investigated the role of PCT as a prognostic marker of supportive modalities (vasopressors, invasive mechanical ventilation, and renal replacement therapy (RRT)) in the intensive care unit (ICU).
Methods: We retrospectively analyzed 2200 PCT and blood cultures from adult cancer patients with suspected sepsis.